effect of intravitreal bevacizumab injection on the corneal endothelial cells: systematic review

ABSTRACT

Introduction:Bevacizumab [Avastin], as an effectiveness treatment modality, is currently used in patients with various ocular disease. However the results have been promising, the use of bevacizumab in the treatment of ocular disease is an off-label application. Hence, the aim of this study was to systematically review the effectiveness of intravitreal injection of bevacizumab on various ocular tissues, especially corneal endothelial cells